New XOMA Antibodies Unveiled at The Society for Immunotherapy of Cancer 31st Annual Meeting Preclinical Data from XOMA’s Novel Anti-IL-2 Immuno-oncology Monoclonal Antibodies Program to be Presented at SITCAdvancing Unique Functional Antibody Antagonists Targeting the Parathyroid Hormone...